Literature DB >> 9778158

The costs of healthcare worker respiratory protection and fit-testing programs.

S E Kellerman1, J I Tokars, W R Jarvis.   

Abstract

OBJECTIVE: We studied hospital costs associated with healthcare worker (HCW) respiratory protection and respirator fit-testing programs recommended by the Centers for Disease Control and Prevention (CDC) and mandated by the Occupational Safety and Health Administration to decrease nosocomial or occupational Mycobacterium tuberculosis (TB).
DESIGN: The number and cost of high-efficiency particulate air (HEPA)-filter and dust-mist (DM) respirators for 1989 to 1994 were obtained from study hospital purchasing departments, and the costs of HCW fit-testing and education programs for 1994 were estimated from information provided by infection control practitioners. Costs of N-class respirator programs were estimated for study hospitals using retrospective cost analysis and an observational study.
SETTING: Four urban hospitals with, and one rural community hospital without, documented nosocomial or occupational transmission of multidrug-resistant TB.
RESULTS: During the study period, four of five hospitals introduced HEPA and DM respirators and respirator education and fit-testing programs. Median costs in 1994 were $83,900 (range, $2,000-$223,000) for respirators and $17,187 (range, $8,736-$26,175) for respiratory fit-testing programs. The projected median annual cost of N95 respirators was $62,023 (range, $270-$422,526).
CONCLUSIONS: Compliance with CDC TB guidelines may require a substantial investment. However, outlays for respirators and education and fit-testing programs are more reasonable than would be suggested by analyses that estimated the costs of preventing one case of nosocomial TB.

Entities:  

Mesh:

Year:  1998        PMID: 9778158     DOI: 10.1086/647888

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  5 in total

Review 1.  Review of economic evaluations of mask and respirator use for protection against respiratory infection transmission.

Authors:  Shohini Mukerji; C Raina MacIntyre; Anthony T Newall
Journal:  BMC Infect Dis       Date:  2015-10-13       Impact factor: 3.090

2.  A randomised controlled pilot study to compare filtration factor of a novel non-fit-tested high-efficiency particulate air (HEPA) filtering facemask with a fit-tested N95 mask.

Authors:  S S W Au; C D Gomersall; P Leung; P T Y Li
Journal:  J Hosp Infect       Date:  2010-03-31       Impact factor: 3.926

3.  Fit factor of masks used by Physicians in Clinical Settings.

Authors:  Borja De-Yñigo-Mojado; Javier Madera-García; Ricardo Becerro-de-Bengoa-Vallejo; Marta Elena Losa-Iglesias; David Rodríguez-Sanz; Marta San-Antolín; Cesar Calvo-Lobo; Daniel López-López
Journal:  Int J Med Sci       Date:  2020-09-23       Impact factor: 3.738

4.  Preventing nosocomial MDR TB transmission in sub Saharan Africa: where are we at?

Authors:  Sonia Menon
Journal:  Glob J Health Sci       Date:  2013-05-15

Review 5.  Evaluation of the rationale for concurrent use of N95 filtering facepiece respirators with loose-fitting powered air-purifying respirators during aerosol-generating medical procedures.

Authors:  Raymond J Roberge
Journal:  Am J Infect Control       Date:  2008-03       Impact factor: 2.918

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.